Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 11/20/2024 | $24.00 → $40.00 | Underperform → Buy | BofA Securities | |
| 11/14/2024 | Buy → Hold | Craig Hallum | ||
| 11/8/2024 | $28.00 → $40.00 | Neutral → Buy | Citigroup | |
| 10/23/2024 | Hold | Needham | ||
| 10/9/2024 | $38.00 | Buy | TD Cowen | |
| 8/23/2024 | $35.00 | Overweight | Piper Sandler | |
| 8/21/2024 | Outperform → Mkt Perform | Raymond James | ||
| 7/19/2024 | $3.00 → $4.00 | Neutral | Citigroup |
BofA Securities upgraded Chewy from Underperform to Buy and set a new price target of $40.00 from $24.00 previously
Craig Hallum downgraded Wag! Group from Buy to Hold
Citigroup upgraded Chewy from Neutral to Buy and set a new price target of $40.00 from $28.00 previously
Ordergroove's technology streamlines the subscription and membership experience, with ready-to-use functionalities like prepaid subscriptions, self-service management, and personalized promotions. Ordergroove, the leading technology platform that powers subscriptions for top brands and retailers, today announced a strategic partnership with PetMed Express, Inc. (NASDAQ:PETS), the original online pet pharmacy dedicated to supporting the health and well-being of four-legged family members. This collaboration marks a significant step in modernizing and scaling PetMeds + PetCareRx's (PETS) subscription and membership capabilities to maximize operational efficiency and deliver innovative and e
SAN DIEGO, Nov. 13, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) today announced Joe Venezia will join the company as Chief Revenue Officer, effective Nov. 17, reporting to Joel Anderson, Chief Executive Officer. In this newly created role, Venezia will be responsible for driving revenue and developing integrated strategies to improve the customer experience. Joe will oversee critical areas that contribute to Petco's growth, including pet care centers, pet and veterinary services, real estate and customer success capabilities. "Joe is a proven sal
Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today that it will report fiscal third quarter 2024 financial results before the market opens on Wednesday, December 4, 2024. Management will host a conference call and webcast to discuss the company's financial results at 8:00 am ET. To access the conference call by phone, please visit this link for registration (Phone Registration Link) to be provided with dial in details, including a unique PIN to access the conference call. To avoid delays, we encourage participants to register in advance or at a minimum 15 minutes before the start of the call. A live webcast and replay of the
SC 13G - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G/A - Chewy, Inc. (0001766502) (Subject)
SC 13G/A - Chewy, Inc. (0001766502) (Subject)
Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today that it will report fiscal third quarter 2024 financial results before the market opens on Wednesday, December 4, 2024. Management will host a conference call and webcast to discuss the company's financial results at 8:00 am ET. To access the conference call by phone, please visit this link for registration (Phone Registration Link) to be provided with dial in details, including a unique PIN to access the conference call. To avoid delays, we encourage participants to register in advance or at a minimum 15 minutes before the start of the call. A live webcast and replay of the
DELRAY BEACH, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its second quarter ended September 30, 2024. Second Quarter Fiscal 2025 Financial Highlights Net sales of $59.6 million.Gross margin of 29.1%, an increase of 0.8% compared to the prior year period.Net income of $2.3 million, or $0.11 per diluted share, compared to net income of $0.7 million, or $0.03 per diluted share, in the prior year period. Adjusted EBITDA of $2.1 million improved sequentially from an Adjusted EBITDA loss of $(1.5) million in the first quarter of fiscal 2025 and compared to Adjusted EBITDA of $
SAN FRANCISCO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Wag!, ((Wag! Group Co., NASDAQ:PET), which strives to be the number one platform to solve the service, product, and wellness needs of the modern U.S. pet household, today announced that it will report third quarter 2024 financial results before market open on Wednesday, November 13, 2024. The Company will host a conference call at 8:30 a.m. Eastern Time to discuss the financial results. Investors and analysts interested in participating in the call are invited to dial 800-717-1738 (international callers please dial 1-646-307-1865) approximately 10 minutes prior to the start of the call. A live audio webcast of the conference call will be av
SAN DIEGO, Nov. 13, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) today announced Joe Venezia will join the company as Chief Revenue Officer, effective Nov. 17, reporting to Joel Anderson, Chief Executive Officer. In this newly created role, Venezia will be responsible for driving revenue and developing integrated strategies to improve the customer experience. Joe will oversee critical areas that contribute to Petco's growth, including pet care centers, pet and veterinary services, real estate and customer success capabilities. "Joe is a proven sal
NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Chewy Inc. (NYSE: CHWY) will replace Stericycle Inc. (NASD: SRCL) in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, November 6. S&P 500 constituent Waste Management Inc. (NYSE:WM) is acquiring Stericycle in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector November 6, 2024 S&P MidCap 400 Addition Chewy CHWY Consumer Discretionary November 6, 2024 S&P MidCap 400 Deletion Stericycle SRCL Industrial For more information about
DELRAY BEACH, Fla., Sept. 12, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of retail and ecommerce veteran Robyn D'Elia as Chief Financial Officer ("CFO") effective September 16, 2024. D'Elia brings over 25 years of experience in financial leadership and strategic planning across multiple industries, including 24 years at Bed Bath & Beyond where she served in senior leadership roles across finance for two decades, and served as CFO from 2018 to 2020. Most recently D'Elia served as CFO at Odeko, a privately held all-in-one operations partner for independent coffee shops, cafes and ot
4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)
4 - Wag! Group Co. (0001842356) (Issuer)
4 - Wag! Group Co. (0001842356) (Issuer)
The Dow Jones index closed lower by more than 350 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform. Super League Enterprise The Trade: Super League Enterprise, Inc. (NASDAQ:SLE) Director Jeff Patrick Gehl bought a total of 50,000 shares at an average price of $1.11. To acquire these shares, it cost around $55,515. What's Happening: On June
- SEC Filing
10-Q - Wag! Group Co. (0001842356) (Filer)
8-K - Wag! Group Co. (0001842356) (Filer)
10-Q - PETMED EXPRESS INC (0001040130) (Filer)
For Immediate Release: December 14, 2023 Today, the U.S. Food and Drug Administration is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law. The agency is concerned because these products contain antimicrobials that are important in human medicine and using them without medical oversight contribut
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - Wag! Group Co. (0001842356) (Issuer)
4 - Wag! Group Co. (0001842356) (Issuer)
